搜尋結果
Weight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO says
Reuters· 3 小時前, opens new tab CEO Dietmar Siemssen said he expects about 4% of the company's revenue ...
Nearly half of illicit crypto volume last year was on Tron blockchain: report
South China Morning Post· 10 小時前The number of blockchain addresses linked to terrorist financing activities on Tron that ...
Walgreens CEO says 'human interface' will help the chain beat Amazon
CNBC· 11 小時前"We will beat Amazon because of the human interface that we offer in communities and ...
AI fails to detect depression signs in social media posts by Black Americans, study finds
Reuters· 12 小時前Analyzing social media using artificial intelligence may pick up signals of depression in white ...
Fake US government scams abound as the FTC fights back
Reuters· 12 小時前March 28 (Reuters) - “I’m from the government, and I’m here to help.” Ronald Reagan once called ...
US FDA extends review of Applied Therapeutics' genetic disease drug
Reuters· 12 小時前The U.S. Food and Drug Administration has extended its review of Applied Therapeutics' ...
Exclusive: China's WuXi AppTec shared US client's data with Beijing, US intelligence ...
Reuters· 13 小時前, opens new tab had transferred U.S. intellectual property to Beijing without consent, ...
Bristol Myers' bowel disease drug fails to meet main goal in late-stage study
Reuters· 13 小時前, opens new tab said on Thursday its experimental drug to treat Crohn's disease, a chronic ...
7 Trends Influencing Health Care and Life Sciences in 2024
The Wall Street Journal· 14 小時前To balance cost concerns with consumer expectations for convenience and digital experiences, ...
Eli Lilly climbs on win for rival weight-loss drug, and we still feel good about Abbott Labs
CNBC· 14 小時前GLP-1 check in : Eli Lilly shares rose about 0.5% after the first major U.S. health insurers ...